BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3367167)

  • 1. The significance of simultaneous estimation of serum creatine kinase and myoglobin in neuromuscular diseases.
    Diószeghy P; Mechler F
    J Neurol; 1988 Jan; 235(3):174-6. PubMed ID: 3367167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of serum myoglobin in neuromuscular diseases and in carrier detection of Duchenne muscular dystrophy.
    Nørregaard-Hansen K; Hein-Sørensen O
    Acta Neurol Scand; 1982 Aug; 66(2):259-66. PubMed ID: 7136489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of the estimation of serum myoglobin in neuromuscular diseases.
    Hische EA; van der Helm HJ
    J Neurol Sci; 1979 Oct; 43(2):243-51. PubMed ID: 512682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myoglobin radioimmunoassay: experience of the diagnosis of skeletal muscle disorders (author's transl)].
    Kiessling WR; Pflughaupt KW
    Arch Psychiatr Nervenkr (1970); 1981; 230(1):49-54. PubMed ID: 7259483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum myoglobin in muscular dystrophy.
    Kagen LJ; Moussavi S; Miller SL; Tsairis P
    Muscle Nerve; 1980; 3(3):221-6. PubMed ID: 7374673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of myoglobin and creatine kinase in Duchenne muscular dystrophy.
    Kiessling WR; Beckmann R
    Klin Wochenschr; 1981 Apr; 59(7):347-8. PubMed ID: 7241957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum myoglobin in Duchenne muscular dystrophy carrier detection: a comparison with creatine kinase and hemopexin using logistic discrimination.
    Percy ME; Pichora GA; Chang LS; Manchester KE; Andrews DF
    Am J Med Genet; 1984 Jun; 18(2):279-87. PubMed ID: 6465202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of diurnal fluctuations between serum myoglobin level and creatine kinase activities in neuromuscular diseases].
    Konagaya M; Konagaya Y; Horikawa H; Takayanagi T
    Rinsho Shinkeigaku; 1984 Mar; 24(3):293-9. PubMed ID: 6540636
    [No Abstract]   [Full Text] [Related]  

  • 9. Activity, creatine kinase, and myoglobin in Duchenne muscular dystrophy: a clue to etiology?
    Florence JM; Fox PT; Planer GJ; Brooke MH
    Neurology; 1985 May; 35(5):758-61. PubMed ID: 4039424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum myoglobin in muscular dystrophy and carrier detection.
    Nicholson LV
    J Neurol Sci; 1981 Sep; 51(3):411-26. PubMed ID: 7276986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum muscle-specific enolase in progressive muscular dystrophy and other neuromuscular diseases.
    Mokuno K; Riku S; Matsuoka Y; Sobue I; Kato K
    J Neurol Sci; 1984 Mar; 63(3):345-52. PubMed ID: 6726277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fluctuation of serum myoglobin levels in Duchenne muscular dystrophy and the carrier.
    Konagaya M; Takayanagi T; Konagaya Y; Sobue I
    J Neurol Sci; 1982 Sep; 55(3):259-65. PubMed ID: 6890096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic value of plasma myoglobin levels in the adult and fetus at-risk for Duchenne muscular dystrophy.
    Edwards RJ; Rodeck CH; Watts DC
    J Neurol Sci; 1984 Feb; 63(2):173-82. PubMed ID: 6707690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creatine kinase isoenzymes in neuromuscular diseases.
    Somer H; Dubowitz V; Donner M
    J Neurol Sci; 1976 Oct; 29(2-4):129-36. PubMed ID: 978205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoassay of serum myoglobin in neuromuscular diseases.
    Askmark H; Osterman PO; Roxin LE; Venge P
    J Neurol Neurosurg Psychiatry; 1981 Jan; 44(1):68-72. PubMed ID: 7205308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB.
    Okamoto F; Sohmiya K; Ohkaru Y; Kawamura K; Asayama K; Kimura H; Nishimura S; Ishii H; Sunahara N; Tanaka T
    Clin Chem Lab Med; 2000 Mar; 38(3):231-8. PubMed ID: 10905760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on the serum biochemistry in carrier detection of Duchenne muscular dystrophy].
    Xie B
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):165-8, 189. PubMed ID: 1889329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum myosin light chain 3 level in neuromuscular diseases.
    Konagaya M; Konagaya Y; Horikawa H; Takayanagi T
    Muscle Nerve; 1987 Jun; 10(5):415-21. PubMed ID: 3112571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum pyruvate kinase in different neuromuscular diseases and in carriers of muscular dystrophy.
    Savonitto C; Bonadonna G; Bongiovanni LG; Duso E; De Grandis D
    Ital J Neurol Sci; 1983 Dec; 4(4):417-22. PubMed ID: 6674240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum creatine kinase BB and MM concentrations determined by radioimmunoassay in neuromuscular disorders.
    Zweig MH; Adornato B; Van Steirteghem AC; Engel WK
    Ann Neurol; 1980 Apr; 7(4):324-8. PubMed ID: 7377757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.